The role of human glutathione S-transferases M1 and T1 in individual susceptibility to bladder cancer

• Published in: Physiological research Vol. 48; no. 6; p. 465
• Main Authors: Salagovic, J, Kalina, I, Habalová, V, Hrivnák, M, Valanský, L, Biros, E
• Format: Journal Article
• Language: English
• Published: Czech Republic 1999
• Subjects: Aged; Case-Control Studies; Female; Genetic Predisposition to Disease; Genotype; Glutathione Transferase - genetics; Glutathione Transferase - metabolism; Humans; Male; Middle Aged; Polymorphism, Genetic; Risk Factors; Smoking - adverse effects; Urinary Bladder Neoplasms - enzymology; Urinary Bladder Neoplasms - epidemiology; Urinary Bladder Neoplasms - genetics; Xenobiotics - metabolism
• ISSN: 0862-8408

Several genes involved in the metabolism of carcinogens have been found to be polymorphic in the human population, and specific alleles are associated with increased risk of cancer at various sites. This study is focused on the polymorphic enzymes glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) that are involved in the detoxification of many xenobiotics involved in the etiology of bladder cancer. To investigate the role of GSTM1 and GSTT1 in bladder carcinogenesis, the polymerase chain reaction was used to determine GSTM1 and GSTT1 genotypes of cancer patients (n = 76) and controls (n = 248). The proportion of putative risk GSTM1 null genotype in the case group was 52.6%, compared to 49.6% in the control group, but the GSTT1 0/0 frequency in the bladder cancer group was significantly higher (P = 0.04) in comparison with the control group (27.6 vs 16.9%). Individuals lacking the GSTT1 gene are at an approximately 1.9-fold higher risk (OR = 1.87, C.I. 95% = 1.03-3.42) of developing bladder cancer in comparison with individuals with at least one active allele in the GSTT1 locus. A significantly higher incidence of GSTM1 deletion genotype (P = 0.02) was found in smokers with bladder cancer compared to the controls (70.6 vs 49.6%). Smokers lacking the GSTM1 gene are at an approximately 2.4-fold higher risk of bladder cancer (OR = 2.44, C.I. 95% = 1.10-5.30). The effect of smoking associated with the GSTT1 0/0 genotype was not found to affect the risk of bladder cancer.